-
Paradigm Therapeutics Recognized Again: SD-101 Nominated for Prestigious Prix Galien USA 2026
A Repeat Achievement in Biotech Innovation Paradigm Therapeutics Inc. has once again solidified its position at the forefront of medical innovation. For the second consecutive year, the company has been nominated for the highly esteemed Prix Galien USA 2026. This recognition highlights the company’s commitment to pushing the boundaries of dermatological science. The Innovation: SD-101…
-
Ascentage Pharma Shares Vision for Global Expansion at J.P. Morgan Conference
NASDAQ: $AAPG The recent 44th Annual J.P. Morgan Healthcare Conference served as a pivotal stage for Ascentage Pharma to articulate its comprehensive strategy for worldwide growth and innovation. The company, a dynamic force in the biopharmaceutical sector, used its presentation slot to detail how it plans to propel its pipeline from clinical promise to global…